New EMA gateway portal available

Starting today, this will be the new electronic submission channel

Starting today, this will be the new electronic submission channel
July 11, 2022

From July 11th, 2022 a new EMA Gateway portal is available, replacing the previous one that is no longer in use. The new portal (Syncplicity Web Client) erases the barrier of using Java as document explorer and is compatible with all internet browsers (not with Internet Explorer).

Please note that you will only be able to send submissions via the Syncplicity Web Client if you have successfully registered, received email confirmation with your login details and subsequently reset your password in Syncplicity. More information on the registration process and submissions can be found in EMA guideline (EMA/737304/2012), available at the link below.

The eSubmission Gateway Web Client is an electronic submission channel that allows the applicants to submit documents supporting all types of applications to the Agency securely over the internet in any electronic format (structured or non-structured). The eSubmission Gateway Web Client users will benefit from an automated confirmation of the technical validation feedback (eCTD only) and an automated upload to the Agency’s eCTD review system. The use of the eSubmission Gateway and the Web Client is mandatory for all human and veterinary submissions, including medical devices.

More information can be found in the European eSubmission webpage.

For further information, you can also contact us at:


Search News & Events

  • Filter by category


Related news and events

NEW! | The 3rd eAF-PMS Newsletter has been published on the EMA website!

This 3rd edition of the eAF-PMS
Newsletter highlights the latest news,
upcoming events and activities planned
for the next months. An updated
timeline of the web-based Human
Variations electronic application
form (eAF) accessible from the
Product Lifecycle Management
(PLM) Portal is now available to all
interested stakeholders. The timeline
highlights important milestones to be
achieved in the upcoming months with
regards to the release of new
functionalities, User Acceptance Testing
(UAT) and start of the transition period.
A version of the timeline highlighting
impacts on the eAF users in the
different periods is also available for
If you are interested in the progress of


During these two interactive days, leaders and world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and new trends. Discussion will focus on the actions, changes, evolutions and re-thinking needed to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to realise the improvements in both health and access.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting